Asahi Kasei Corporation (ASAA BE) stock market data APIs
€6.9961
0(0%)
as of November 7, 2025
Try our APIs with
free plan!
Asahi Kasei Corporation Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ASAA.BE.
Prev. Close
6.9961
Open
6.9961
High
6.9961
Low
6.9961
52 wk Range
5.4995-7.046
Market Cap
11 940 M
Dividends (Yield)
2.7907
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Asahi Kasei Corporation data using free add-ons & libraries
Get Asahi Kasei Corporation Fundamental Data
Asahi Kasei Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 19.69
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Asahi Kasei Corporation News
New
Asahi Kasei (TSE:3407) Margin Gains Reinforce Bullish Narratives After Five-Year Earnings Decline Reversal
Asahi Kasei (TSE:3407) reported net profit margins of 4%, up from 2.4% last year. Earnings growth over the past year reached a stellar 76.6%. Looking ahead, management is guiding for 13.28% earnings g...
Asahi Kasei Licenses Novel Electrolyte Technology to EAS Batteries for the Market Launch of an Ultra-High-Power Cell
EAS ultra-high-power lithium-ion cell DUESSELDORF, Germany, November 04, 2025--(BUSINESS WIRE)--Diversified global manufacturer Asahi Kasei and German battery manufacturer EAS Batteries signed a lice...
Calliditas Therapeutics to Present at the American Society of Nephrology Kidney Week
STOCKHOLM, Nov. 4, 2025 /PRNewswire/ -- Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data will be presented at the 2025 American Society of Nephrology Kidney ...
Nefecon Included in the Updated KDIGO Clinical Practice Guideline, Strengthening Asahi Kasei’s Position in IgA Nephropathy Treatment
The final 2025 KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function CHELMSFORD, Mass. & TOKYO, November 04, ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
